216 related articles for article (PubMed ID: 27922279)
1. Clinical experience with an ovarian stimulation protocol for intrauterine insemination adopting a gonadotropin releasing hormone antagonist at low dose.
Ponzano A; Colangelo EC; Di Biase L; Romani F; Tiboni GM
Gynecol Endocrinol; 2017 Mar; 33(3):208-211. PubMed ID: 27922279
[TBL] [Abstract][Full Text] [Related]
2. Multifollicular recruitment in combination with gonadotropin-releasing hormone antagonist increased pregnancy rates in intrauterine insemination cycles.
Gómez-Palomares JL; Acevedo-Martín B; Chávez M; Manzanares M; Ricciarelli E; Hernández ER
Fertil Steril; 2008 Mar; 89(3):620-4. PubMed ID: 17678911
[TBL] [Abstract][Full Text] [Related]
3. The addition of GnRH antagonists in intrauterine insemination cycles: a pilot study.
Graziano A; Caserta D; Piva I; Lo Monte G; Bordi G; Martini F; Tognon M; Marci R
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1604-10. PubMed ID: 23832726
[TBL] [Abstract][Full Text] [Related]
4. Role of gonadotropin-releasing hormone antagonist in the management of subfertile couples with intrauterine insemination and controlled ovarian stimulation.
Bakas P; Konidaris S; Liapis A; Gregoriou O; Tzanakaki D; Creatsas G
Fertil Steril; 2011 May; 95(6):2024-8. PubMed ID: 21334613
[TBL] [Abstract][Full Text] [Related]
5. Use of gonadotropin-releasing hormone antagonists to overcome the drawbacks of intrauterine insemination on weekends.
Checa MA; Prat M; Robles A; Carreras R
Fertil Steril; 2006 Mar; 85(3):573-7. PubMed ID: 16500321
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin releasing hormone antagonist use in controlled ovarian stimulation and intrauterine insemination cycles in women with polycystic ovary syndrome.
Ozelci R; Dilbaz S; Dilbaz B; Cırık DA; Yılmaz S; Tekin OM
Taiwan J Obstet Gynecol; 2019 Mar; 58(2):234-238. PubMed ID: 30910145
[TBL] [Abstract][Full Text] [Related]
7. Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles.
Seow KM; Lin YH; Huang LW; Hsieh BC; Huang SC; Chen CY; Chen PH; Tzeng CR; Hwang JL
Gynecol Endocrinol; 2007 Jun; 23(6):338-42. PubMed ID: 17616858
[TBL] [Abstract][Full Text] [Related]
8. Antagonist protocol versus clomiphene in unexplained infertility: A randomized controlled study.
Nada AM; ElSetohy KA; Banat MM; Shaheen AF
Taiwan J Obstet Gynecol; 2016 Jun; 55(3):326-30. PubMed ID: 27343309
[TBL] [Abstract][Full Text] [Related]
9. Cetrorelix lowers premature luteinization rate in gonadotropin ovulation induction-intrauterine insemination cycles: a randomized-controlled clinical trial.
Steward RG; Gill I; Williams DB; Witz CA; Griffith J; Haddad GF
Fertil Steril; 2011 Jan; 95(1):434-6. PubMed ID: 20810107
[TBL] [Abstract][Full Text] [Related]
10. Comparison of luteal phase profile in gonadotrophin stimulated cycles with or without a gonadotrophin-releasing hormone antagonist.
Ragni G; Vegetti W; Baroni E; Colombo M; Arnoldi M; Lombroso G; Crosignani PG
Hum Reprod; 2001 Nov; 16(11):2258-62. PubMed ID: 11679500
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of cetrorelix for the prevention of premature luteinizing hormone surge during controlled ovarian stimulation using letrozole and gonadotropins: a randomized trial.
Lee TH; Lin YH; Seow KM; Hwang JL; Tzeng CR; Yang YS
Fertil Steril; 2008 Jul; 90(1):113-20. PubMed ID: 18054932
[TBL] [Abstract][Full Text] [Related]
12. Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility.
Felberbaum RE; Reissmann T; Küpker W; Bauer O; al Hasani S; Diedrich C; Diedrich K
Eur J Obstet Gynecol Reprod Biol; 1995 Aug; 61(2):151-5. PubMed ID: 7556837
[TBL] [Abstract][Full Text] [Related]
13. Timing ovulation for intrauterine insemination with a GnRH antagonist.
Gómez-Palomares JL; Juliá B; Acevedo-Martín B; Martínez-Burgos M; Hernández ER; Ricciarelli E
Hum Reprod; 2005 Feb; 20(2):368-72. PubMed ID: 15567879
[TBL] [Abstract][Full Text] [Related]
14. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.
Griesinger G; Schultze-Mosgau A; Dafopoulos K; Schroeder A; Schroer A; von Otte S; Hornung D; Diedrich K; Felberbaum R
Hum Reprod; 2005 May; 20(5):1200-6. PubMed ID: 15665010
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol.
Koichi K; Yukiko N; Shima K; Sachiko S
J Assist Reprod Genet; 2006 May; 23(5):223-8. PubMed ID: 16786420
[TBL] [Abstract][Full Text] [Related]
16. GnRH antagonists and mild ovarian stimulation for intrauterine insemination: a randomized study comparing different gonadotrophin dosages.
Ragni G; Alagna F; Brigante C; Riccaboni A; Colombo M; Somigliana E; Crosignani PG
Hum Reprod; 2004 Jan; 19(1):54-8. PubMed ID: 14688156
[TBL] [Abstract][Full Text] [Related]
17. Effect of GnRH antagonists on clinical pregnancy rates in ovulation induction protocols with gonadotropins and intrauterine insemination.
Dansuk R; Gonenc AI; Sudolmus S; Yucel O; Sevket O; Köroğlu N
Singapore Med J; 2015 Jun; 56(6):353-6. PubMed ID: 25532515
[TBL] [Abstract][Full Text] [Related]
18. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O
Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
[TBL] [Abstract][Full Text] [Related]
19. Low-dose human menopausal gonadotrophin versus clomiphene citrate in subfertile couples treated with intrauterine insemination: a randomized controlled trial.
Peeraer K; Debrock S; De Loecker P; Tomassetti C; Laenen A; Welkenhuysen M; Meeuwis L; Pelckmans S; Mol BW; Spiessens C; De Neubourg D; D'Hooghe TM
Hum Reprod; 2015 May; 30(5):1079-88. PubMed ID: 25788569
[TBL] [Abstract][Full Text] [Related]
20. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
Moro F; Scarinci E; Palla C; Romani F; Familiari A; Tropea A; Leoncini E; Lanzone A; Apa R
Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
